Apellis Pharmaceuticals to Host Conference Call on May 4, 2022 to Discuss First Quarter 2022 Financial Results

Rhea-AI Summary

Apellis Pharmaceuticals, a leader in complement medicine, will host a conference call and webcast on May 4, 2022, at 4:30 p.m. ET to discuss its first quarter 2022 financial results. The live call can be accessed by pre-registering online, and a replay will be available for 30 days. The company is committed to delivering transformative therapies for rare, retinal, and neurological diseases, highlighted by the launch of the first new class of complement medicine in 15 years with its targeted C3 therapy.

Positive

• Company hosted a conference call to discuss Q1 2022 financial results, indicating transparency.
• Leadership in complement medicine with the approval of the first targeted C3 therapy.

Negative

• None.

WALTHAM, Mass., April 26, 2022 (GLOBE NEWSWIRE) --  Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will host a conference call and webcast to discuss its first quarter 2022 financial results on Wednesday, May 4, 2022 at 4:30 p.m. ET.

To access the live call by phone, please pre-register for the call here. The conference ID is 7978519. A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for 30 days following the event.

About Apellis 
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in complement, we ushered in the first new class of complement medicine in 15 years with the approval of the first and only targeted C3 therapy. We are advancing this science to continually develop transformative medicines for people living with rare, retinal, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178

FAQ

When is Apellis Pharmaceuticals’ Q1 2022 financial results conference call?

The conference call is scheduled for May 4, 2022, at 4:30 p.m. ET.

How can I access the live call for Apellis Pharmaceuticals’ Q1 2022 results?

You can access the live call by pre-registering online.

What is Apellis Pharmaceuticals known for?

Apellis is known for its leadership in complement medicine, particularly the first targeted C3 therapy.